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Abstract 
Alzheimer’s disease (AD) is a slowly progreessing and chronic neurodegenerative disorder which has now become a major health 
concern worldwide. The previous literature has shown that oxidative stress is one of the most important risk factors behind the 
etiopathogenesis of AD. Oxidative stress subsequently leads to the production of Reactive Oxygen Species (ROS).  
D-Galactose, a reducing sugar, reacts with amines of amino acids non-enzymatically in the proteins and peptides to form 
Advanced Glycation End products which further activates its receptors coupled to biochemical pathways that stimulate ROS 
production and induces mitochondrial dysfunction which damages the neuron intracellularly. High dosage of D-Galactose also 
suppresses the production of nerve growth factors and its associated proteins which results in the degeneration of nerve cells 
and reduction of acetylcholine levels in brain regions. This article put forwards the advantages of using Lactic Acid Bacteria 
(Probiotics) possessing anti-oxidant properties and which produces Acetyl Choline against D-Galactose induced Alzheimer’s 
disease. 
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Introduction 
Alzheimer’s disease (AD) is one of the most chronic and slowly 
progressing neurodegenerative disorder known till date. 
Approximately, 44 million patients have been already affected 
by Alzheimer’s related dementia and the researchers believe 
that more than 4 million and 5.3 million individuals have 
Alzheimer’s disease in India and the United States, 
respectively [1,2].  
 
It is predicted that, by 2050, more than 13.5 million 
individuals will be having AD [3]. AD is often associated with 
cognition and memory deficits which arises due to 
accumulation of the amyloid plaques and neurofibrillary 
tangles along with disruption of cholinergic neurons in the 
basal forebrain of aged people [4]. 
 
The cognitive decline is associated with the AD pathogenesis 
which is due to decrease in Acetyl Choline (A.Ch) [5], which 
also proposes that deficit of Acetylcholine is life-threatening in 
the creation of the symptoms of AD [6]. Therefore, a major 
milestone in the treatment of AD should involve an attempt to 
prevent the degeneration of cholinergic neurons and increase 
the Acetylcholine levels in central nervous system. In addition, 
several reserachers suggested that Reactive Oxygen species 
(ROS) is associated with etiopathogenesis of AD and it leads to 
a cumulative damage of cellular macromolecules and 
impairment of mitochondria function which further leads to a 
decrease in cellular energy production [7]. 
 
Prolonged supplementation of D-Galactose induces oxidative 
stress followed by mitochondrial dysfunction and intracellular 
damage of neurons, accelerating aging, and influencing age-
related cognitive decline in experimental animals [8]. 
 
D-Galactose Induced Alzheimer’s Disease 
D-Galactose induces aging-inducible oxidative stress in vivo, 
which resembles the natural aging process in mice [9, 10]. D-
Galactose is metabolized to galactose-1-phosphate at a 
normal concentration by D-galactokinase or galactose-1-
phosphate uridyl-transferase, but not at high levels. Instead, 
at increased concentration, D-galactose is converted to 
galactitol, which accumulates in cells and then induces 
osmotic stress and generates reactive oxygen species (ROS) 
which induces mitochondrial dysfunction and is the major 
cause of intracellular damage [11]. D-Galactose also reacts 
with the free amines of amino acids in peptides and proteins 
forming advanced glycation end-products (AGE) [12]. High 
dosage of D-Galactose also suppresses the expression of nerve 
growth factors and its associate protein resulting in the 
degeneration of nerve cells and reduction of acetylcholine 
levels in brain regions (Figure 1). 
 
 
Figure 1. D-Galactose induced Alzheimer’s Disease 
 
ROS activate inflammatory signaling molecules, such as the 
phosphatidylinositol 3-kinase (PI3K), nuclear factor-kappa B 
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(NF-kB), Janus kinase (JAK) and mitogen-activated protein 
kinases (MAPK). It also induces the expression of tumor 
necrosis factor-alpha, interleukin-1b (IL-1b) and IL-6 [13]. D-
Galactose increases replicative senescence markers p16 
expression and telomere shortening but reduces doublecortin 
(DCX) expression [14]. Therefore, D-galactose continuously 
stimulates low-grade inflammation, which is associated with 
the acceleration of aging. 
 
Lactic Acid Bacteria (Probiotics) and D-Galactose 
Induced Alzheimer’s Disease 
Lactic acid bacteria (LAB) are gram-positive, acid-tolerant and 
generally non-sporulating bacteria. The LAB is found in various 
food stuff like cheese, yogurt, and among the vagina and 
gastrointestinal microbiota. LAB are considered as safe food 
products [15], which are the best studied amongst the 
beneficial probiotics useful for the prevention of diarrhea, 
lactose intolerance, treating ulcer, infectious disease 
prevention, restore the composition of the gut microbiome 
and introduce beneficial functions to host through immune, 
neuro modulation [16].  
 
Lactobacillus is a gram-positive facultative anaerobic or 
microaerophilic rod-shaped bacteria. They also possesss 
various properties like anticancer, antioxidant, antidiabetic, 
antiobesity, and antihyperlipidemic effects [17].  
 
Recent studies have found that the L. plantarum versus 
pentosus showed a protective effect against memory deficit in 
AD-induced mice by D-Galactose and scopolamine [12,18]. 
Further, another study reported that L. Plantarum NDC75017 
improves the learning and memory ability in aging rats [19]. 
Previous reports proved that strong antioxidants increases the 
Na+, K+-ATPases activities by decreasing AChE (Acetyl 
cholinesterase) levels and improves the cognition by 
enhancing cholinergic transmission [20]. 
 
Lactobacillus plantarum MTCC1325 strain has the ability to 
produce Acetylcholine Neurotransmitter via both externally 
and internally pathway [21] and this strain also possess 
potential antioxidant activity. 
 
Chronic injection of D-Galactose induces memory impairment, 
neurodegeneration and oxidative damage in mice [22]. L. 
plantarum MTCC 1325 has the ability to produce the 
neurotransmitter viz. Acetylcholine [23] and also possesses 
potential antioxidant activity.  
 
Biochemically, it was well established that AD has been 
related to a significant decrease in the brain neurotransmitter 
ACh [24] and oxidative stress, eventually leading to imbalance 
production and detoxification of ROS, which is considered to 
be the important factor in the development of AD. AD-model 
rats showed a significant decline in total body weight, organ 
index, hair loss and skin elasticity[25].  Chronic administration 
of D-Galactose caused significant decline in spatial memory 
and reduced gross behaviorall activity which suggests 
impairment of memory [8]. 
 
From the comparative studies conducted for 60 days in rats, it 
was evident that chronic administration of L. plantarum 
MTCC1325 for 60 days showed significant improvement and 
recovery from AD. There was significant improvement in the  
activities of the membrane transport ATPases system in the 
selected brain regions of AD-induced group as well. Further, it 
was revealed that L. Plantarum MTCC1325 protects the 
neurons by stabilizing the structural and functional integrity of 
the biological membranes through the regulation of ionic 
concentration gradient by its antioxidant properties [26]. 
 
Similarly, the results on the cholinergic system indicated that 
chronic administration of D-Galactose caused a significant 
reduction in ACh level in brain due to dysfunction of 
cholinergic neurons and reduced activity of Choline 
acetyltransferase [27] while elevation in AChE activity was 
responsible for cognitive deficit, this condition was 
significantly ameliorated in both the regions of brain such as 
hippocampus and cerebral cortex by oral supplementation of 
L. plantarum MTCC1325.  
 
This may be associated with its potential antioxidant nature, 
Acetylcholine producing activities of L. plantarum MTCC1325 
and also bidirectional communication between the Gut-Bain 
Axis (Enteric Nervous System) [28]. The recent reviews on Gut-
Bain Axis communication describe the bacteria (micro biome) 
present in the gastro-intestinal tract may communicate with 
the brain and nervous system by different ways. 
 
Microbes have the ability to produce neurochemicals or 
neurotransmitters that are exact analoges in structure to 
those produced by the host nervous system and act as 
vehicles for neurotransmitters and influence the mood and 
behavior [29]. Microbes have also shown immunomodulatory 
effect by the release of host immune factors such as cytokines 
and inflammatory mediators that have known neuronal 
targets within both the CNS & ENS [30]. Most of the lactic acid 
bacteria and Probiotics may also activate the vagal nerves, 
which interacts with all neurons involved in the alleviation of 
behavioural changes like anxiety, learning and memory, 
Depression etc. [28]. It has been demonstrated that a 
probiotic bacterium (L. rhamnosus JB-1) influences the 
emotional behaviour in mice mediated via GABA receptor 
[31].  
 
Hence by above studies, it is observed that probiotics 
especially LAB could be useful in preventing/treating D-
Galactose Induced Alzheimer’s Disease. However, further 
research is required, so on to  better  understand the possible 
role of Lactobacillus strains in the protection against 
neurodegenerative diseases. 
 
Conclusion 
Antioxidant and ACh producing L. plantarum MTCC 1325 has 
Anti-Alzheimer properties against D-Galactose induced 
Alzheimer’s disease since it resulted in body weight gain and 
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organ index, improved the behavioral activity and learning 
skills through an elevation in the cholinergic neurotransmitter 
in the hippocampus and cerebral cortex regions of the brain 
and restored histopathological abnormalities back to the 
normal conditions.All these preliminary findings suggested 
that, the L. plantarum MTCC 1325 might have exerted 
ameliorative effect against Alzheimer’s disease induced by D-
Galactose. 
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